PCI Pharma adds another San Diego facility as storage needs grow

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/backyardproduction)
(Image: Getty/backyardproduction)

Related tags: Pci pharma services, San diego, facility, Clinical operations, Clinical trials, Research, Logistics

PCI Pharma Services adds a third facility in San Diego as it continues to grow its west coast clinical operations.

The biopharmaceutical outsourcing services provider currently has eight global clinical locations across the US, EU, and the Asia-Pacific region. Through its existing sites, PCI is supporting clinical trials in 100 countries worldwide.

The additional site in San Diego will be a 38,000 square-foot facility less than a mile from PCI’s existing San Diego campus. The company said the new facility will serve as its main storage, logistics, and distribution center for its west coast operations as the company’s needs are projected to grow.

Mark Shepanski, executive director of operations and site lead for PCI San Diego, told us, “Our west coast clinical trial operations have grown in every area. We are seeing packaging and labeling growth, storage growth and growth for our distribution operations. The growth reflects the addition of new clients as well as the success of our current clients.”

Shepanski said the growth stems from its current clinical base as well as the progression and expansion of early-phase clinical studies moving into late-stage clinical trials.

Set to be completed in the fourth quarter of 2019, the new site will be equipped for cold chain requirements for shipping between 2-8°C, -20°C, and -80°C as well as expanded ultra-low freezer capabilities and cryogenic liquid nitrogen storage at -196°C.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us


View more